{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:27:55Z","timestamp":1765294075588},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1978,4,1]],"date-time":"1978-04-01T00:00:00Z","timestamp":260236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1978,4]]},"DOI":"10.1007\/bf01477394","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T16:15:50Z","timestamp":1113408950000},"page":"341-349","source":"Crossref","is-referenced-by-count":6,"title":["Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism"],"prefix":"10.1007","volume":"56","author":[{"given":"U.","family":"Abshagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sp\ufffdrl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sch\ufffdnesh\ufffdfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"L'age","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Oelkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Abshagen, U., Sp\u00f6rl, S., L'age, M.: Non-interaction of spironolactone medication and cortisol metabolism in man. Klin. Wschr. (1978 in press)","DOI":"10.1007\/BF01478568"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1210\/jcem-44-6-1190","volume":"44","author":"U. Abshagen","year":"1977","unstructured":"Abshagen, U., Sp\u00f6rl, S., Sch\u00f6nesh\u00f6fer, M., Oelkers, W.: Increased plasma 11-deoxycorticosterone during spironolactone medication. J. clin. Endocrinol. Metab.44, 1190?1193 (1977)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/endo-99-4-1097","volume":"99","author":"S. Cheng","year":"1976","unstructured":"Cheng, S., Suzuki, K., Sad\u00e9e, W.: Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450 and 11?-and 18-hydroxylation in bovine and human adrenal cortical mitochondria. Endocrinology99, 1097?1106 (1976)","journal-title":"Endocrinology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.1971.tb00565.x","volume":"2","author":"G. D\u00fcsterdieck","year":"1971","unstructured":"D\u00fcsterdieck, G., McElwee, G.: Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Europ. J. clin. Invest.2, 32?38 (1971)","journal-title":"Europ. J. clin. Invest."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00499670","volume":"273","author":"H. Erbler","year":"1972","unstructured":"Erbler, H.: Stimulation of aldosterone production in vitro and its inhibition by spironolactone. Naunyn-Schmiedeberg's Arch. Pharmacol.273, 366?375 (1972)","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00501155","volume":"277","author":"H. Erbler","year":"1973","unstructured":"Erbler, H.: On the mechanism of the inhibitory action of the spironolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol.277, 139?149 (1973)","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00501467","volume":"285","author":"H. Erbler","year":"1974","unstructured":"Erbler, H.: Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man. Naunyn-Schmiedeberg's Arch. Pharmacol.285, 395?401 (1974a)","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR8","first-page":"145","volume":"286","author":"H. Erbler","year":"1974","unstructured":"Erbler, H.: The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man. Naunyn-Schmiedeberg's Arch. Pharmacol.286, 145?156 (1974b)","journal-title":"Pharmacol."},{"key":"CR9","first-page":"613","volume":"15","author":"A. Finn","year":"1976","unstructured":"Finn, A., Finn, C., Sad\u00e9e, W.: Chemical structure and aldosterone receptor affinity of canrenoate-potassium metabolites in rabbits. Res. Commun. Chem. Path. Pharmacol.15, 613?625 (1976)","journal-title":"Res. Commun. Chem. Path. Pharmacol."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0006-2952(74)90386-4","volume":"23","author":"J. Funder","year":"1974","unstructured":"Funder, J., Feldman, D., Highland, E., Edelman, I.: Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors. Biochem. Pharmacol.23, 1493?1501 (1974)","journal-title":"Biochem. Pharmacol."},{"key":"CR11","first-page":"709","volume":"198","author":"J. Greiner","year":"1976","unstructured":"Greiner, J., Kramer, R., Jarrel, J., Colby, H.: Mechanism of action of spironolactone on adrenocortical function in guinea pigs. J. Pharmacol. exp. Ther.198, 709?715 (1976)","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/endo-67-1-125","volume":"67","author":"C. Kagawa","year":"1960","unstructured":"Kagawa, C.: Bocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spironolactone. Endocrinology67, 125?132 (1960)","journal-title":"Endocrinology"},{"key":"CR13","first-page":"467","volume":"3","author":"A. Karim","year":"1975","unstructured":"Karim, A., Hribar, J., Aksamit, W., Doherty, M., Chinn, L.: Spironolactone metabolism in man studied by gas chromatography-mass spectrometry. Drug Metab. Dispos.3, 467?478 (1975)","journal-title":"Drug Metab. Dispos."},{"key":"CR14","first-page":"547","volume":"4","author":"A. Karim","year":"1976","unstructured":"Karim, A., Kook, C., Zitzewitz, D., Zagarella, J., Doherty, M., Campion, J.: Species differences in the metabolism and disposition of spironolactone. Drug Metab. Dispos.4, 547?555 (1976)","journal-title":"Drug Metab. Dispos."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0028-1106260","volume":"100","author":"F. Klumpp","year":"1975","unstructured":"Klumpp, F., Braun, B., Klaus, D., Lemke, R., Zehner, J., Z\u00f6fel, P.: Spironolacton and Thiabutazid bei der Behandlung der essentiellen Hypertonie. Dtsch. med. Wschr.100, 577?584 (1975)","journal-title":"Dtsch. med. Wschr."},{"issue":"Suppl. II","key":"CR16","first-page":"177","volume":"XX","author":"J. Ledingham","year":"1967","unstructured":"Ledingham, J., Brill, M., Laragh, J.: The meaning of aldosteronism in hypertensive disease. Circ. Res., Suppl. II to Vols. XX and XXI, 177?186 (1967)","journal-title":"Circ. Res."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF01745487","volume":"46","author":"D. Lommer","year":"1968","unstructured":"Lommer, D., D\u00fcsterdieck, G., Jahnecke, J., Vecsei, P., Wolff, H.: Sekretion, Plasmakonzentration, Verteilung, Stoffwechsel und Ausscheidung von Aldosteron bei Gesunden und Kranken. Klin. Wschr.46, 741?751 (1968)","journal-title":"Klin. Wschr."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.71.4.1431","volume":"71","author":"D. Marver","year":"1974","unstructured":"Marver, D., Stewart, J., Funder, J., Feldman, D., Edelman, J.: Renal aldosterone receptors: studies with3H-aldosterone and the anti-mineralocorticoid3H-spironolactone (SC-26304). Proc. Nat. Acad. Sci.71, 1431?1435 (1974)","journal-title":"Proc. Nat. Acad. Sci."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0022-4731(76)90190-4","volume":"7","author":"P. Mason","year":"1976","unstructured":"Mason, P., Fraser, R., Morton, J., Semple, P., Wilson, A.: The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man. J. Steroid Biochem.7, 859?861 (1976)","journal-title":"J. Steroid Biochem."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1210\/endo-94-6-1628","volume":"94","author":"R. Menard","year":"1974","unstructured":"Menard, R., Stripp, B., Gillette, J.: Spironolactone and testicular cytochrome P-450: decreased testosterone formation in several species and changes in hepatic drug metabolism. Endocrinology94, 1628?1636 (1974a)","journal-title":"Endocrinology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/0024-3205(74)90330-0","volume":"15","author":"R. Menard","year":"1974","unstructured":"Menard, R., Martin, H., Stripp, B., Gilette, J., Bartter, F.: Spironolactone and cytochrome P-450: impairment of steroid hydroxylation in the adrenal cortex. Life Sci.15, 1639?1648 (1974b)","journal-title":"Life Sci."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cpt1974162336","volume":"16","author":"W. Mroczek","year":"1974","unstructured":"Mroczek, W., Davidov, M., Horoschak, A., Finnerty, F.: Canrenoate in normal man. Clin. Pharmacol. Ther.16, 336?342 (1974)","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl.","key":"CR23","first-page":"41","volume":"152","author":"L. Nocke","year":"1971","unstructured":"Nocke, L., Breuer, H., Klink, R., Lichton, I., Nocke: Wirkung von Spironolakton auf die Ausscheidung von C21- C19- und C18-Steroiden in Urin bei Schwangeren und bei Nichtschwangeren. Acta endocr. (Kbh), Suppl.152, 41 (1971)","journal-title":"Acta endocr."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-39-5-882","volume":"39","author":"W. Oelkers","year":"1974","unstructured":"Oelkers, W., Sch\u00f6nesh\u00f6fer, M., Bl\u00fcmel, A.: Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man. J. clin. Endocrinol. Metab.39, 882?890 (1974)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jps.2600610719","volume":"61","author":"W. Sad\u00e9e","year":"1972","unstructured":"Sad\u00e9e, W., Dagcioglu, M., Riegelman, S.: Fluorimetric microassay for spironolactone and its metabolites in biological fluids. J. pharm. Sci.61, 1126?1129 (1972)","journal-title":"J. pharm. Sci."},{"issue":"Suppl.","key":"CR26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1530\/acta.0.080S116","volume":"193","author":"M. Sch\u00f6nesh\u00f6fer","year":"1975","unstructured":"Sch\u00f6nesh\u00f6fer, M.: Suitability of four standard curve models for computer evaluation of steroid and peptid radioimmunoassays. Acta endocr. (Kbh), Suppl.193, 116 (1975)","journal-title":"Acta endocr."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0022-4731(77)90199-6","volume":"8","author":"M. Sch\u00f6nesh\u00f6fer","year":"1977","unstructured":"Sch\u00f6nesh\u00f6fer, M.: Simultaneous determination of eight adrenal steroids in human serum by radioimmunoassay. J. Steroid Biochem.8, 995?1009 (1977)","journal-title":"J. Steroid Biochem."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/jcem-41-4-777","volume":"41","author":"B. Stripp","year":"1975","unstructured":"Stripp, B., Taylor, A., Bartter, F., Gillette, J., Loriaux, D., Easely, R., Menard, R.: Effect of spironolactone on sex hormones in man. J. clin. Endocrin. Metab.41, 777?781 (1975)","journal-title":"J. clin. Endocrin. Metab."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-39-4-734","volume":"39","author":"J. Sundsfjord","year":"1974","unstructured":"Sundsfjord, J., Marton, P., Jorgensen, H., Aakvaag, A.: Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism. J. clin. Endocrinol. Metab.39, 734?739 (1974)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/jcem-41-1-126","volume":"41","author":"S. Tan","year":"1975","unstructured":"Tan, S., Mulrow, P.: The contribution of the zona fasciculata and glomerulosa to plasma 11-deoxycorticosterone levels in man. J. clin. Endocrinol. Metab.41, 126?130 (1975)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jcem-41-4-791","volume":"41","author":"S. Tan","year":"1975","unstructured":"Tan, S., Mulrow, P.: Interference of spironolactone in 11-deoxycorticosterone radioassays. J. clin. Endocrinol. Metab.41, 791?792 (1975)","journal-title":"J. clin. Endocrinol. Metab."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9149(73)80044-X","volume":"32","author":"E. Vaughan","year":"1973","unstructured":"Vaughan, E., Laragh, J., Gavras, I., B\u00fcchler, F., Gavras, H., Brunner, H., Baer, L.: Volume factor in low and normal renin essential hypertension. Amer. J. Cardiol.32, 523?532 (1973)","journal-title":"Amer. J. Cardiol."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF01931912","volume":"28","author":"P. Vecsei","year":"1972","unstructured":"Vecsei, P., Penke, B., Joumaah, A.: Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine. Experientia28, 622?624 (1972)","journal-title":"Experientia"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0028-1095668","volume":"7","author":"E. Young Lai","year":"1975","unstructured":"Young Lai, E., Smith, S., Choy, E.: Interference by spironolactone of radioassays for progesterone and estrogen. Horm. Metab. Res.7, 364?365 (1975)","journal-title":"Horm. Metab. Res."}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01477394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01477394\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01477394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T07:32:12Z","timestamp":1556868732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01477394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,4]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1978,4]]}},"alternative-id":["BF01477394"],"URL":"https:\/\/doi.org\/10.1007\/bf01477394","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,4]]}}}